Difference between revisions of "Part:BBa K2440011"
(→Usage and Biology) |
(→Usage and Biology) |
||
| Line 9: | Line 9: | ||
MiRNA locker assembled by using this modularized DNA part was able to bind let-7a in an Ago2 dependent manner, that is, knockdown of let-7a was achieved by transfecting cells with miRNA locker. | MiRNA locker assembled by using this modularized DNA part was able to bind let-7a in an Ago2 dependent manner, that is, knockdown of let-7a was achieved by transfecting cells with miRNA locker. | ||
| − | Let7 is one of the founding members of the miRNA family. It was first found in C.elegans. There are several human let7 have the same base sequence with C.elegans let7, let7a1 is one in this group. The expression of let7 is barely detectable in embryonic stages, but it increases after differentiation and in mature tissues.1 | + | Let7 is one of the founding members of the miRNA family. It was first found in C.elegans. There are several human let7 have the same base sequence with C.elegans let7, let7a1 is one in this group. The expression of let7 is barely detectable in embryonic stages, but it increases after differentiation and in mature tissues.<sup>1</sup> |
HRAS, KRAS, and NRAS, these three human RAS genes have several let-7 complementary sites in their Untranslated Regions. It allows let-7 miRNA to control their function. The level of let7 in lung tumor’s cell is much lower than in normal cell. The expression of the RAS proteins was significantly higher in lung tumors, it suggests a possible mechanism for let-7 in cancer.2 | HRAS, KRAS, and NRAS, these three human RAS genes have several let-7 complementary sites in their Untranslated Regions. It allows let-7 miRNA to control their function. The level of let7 in lung tumor’s cell is much lower than in normal cell. The expression of the RAS proteins was significantly higher in lung tumors, it suggests a possible mechanism for let-7 in cancer.2 | ||
Revision as of 00:31, 1 November 2017
let-7a target sequence
It is the target sequence of let-7a, a modularized DNA part from a set of chemically synthetic oligo DNA library.
Usage and Biology
MiRNA locker assembled by using this modularized DNA part was able to bind let-7a in an Ago2 dependent manner, that is, knockdown of let-7a was achieved by transfecting cells with miRNA locker.
Let7 is one of the founding members of the miRNA family. It was first found in C.elegans. There are several human let7 have the same base sequence with C.elegans let7, let7a1 is one in this group. The expression of let7 is barely detectable in embryonic stages, but it increases after differentiation and in mature tissues.1
HRAS, KRAS, and NRAS, these three human RAS genes have several let-7 complementary sites in their Untranslated Regions. It allows let-7 miRNA to control their function. The level of let7 in lung tumor’s cell is much lower than in normal cell. The expression of the RAS proteins was significantly higher in lung tumors, it suggests a possible mechanism for let-7 in cancer.2
Compared with cirrhotic livers, the level of LET7A1 was reduced about 70%in cancered livers. It was also happened in all HCC-derived cell lines examined. It may shows that the low level of the expression of LET7A1 promotes the development of cancer.
Sequence and Features
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Experimental Validation
This part is sequenced as correct after construction.